COVID-19 linked to rise in anti-MDA5 autoimmunity

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2024-06-05 DOI:10.1038/s41584-024-01134-4

Jessica McHugh

引用次数: 0

Abstract

Researchers have introduced the term ‘MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic’ (MIP-C) to describe cases of MDA5 autoimmunity that surged during the COVID-19 pandemic.

查看原文本刊更多论文

COVID-19与抗MDA5自身免疫的上升有关。

研究人员提出了 "与 COVID-19 大流行同时发生的 MDA5 自身免疫和间质性肺炎"（MIP-C）一词，以描述 COVID-19 大流行期间激增的 MDA5 自身免疫病例。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.